Cargando…
Development and validation of prognostic markers in sarcomas base on a multi-omics analysis
BACKGROUND: In sarcomas, the DNA copy number and DNA methylation exhibit genomic aberrations. Transcriptome imbalances play a driving role in the heterogeneous progression of sarcomas. However, it is still unclear whether abnormalities of DNA copy numbers are systematically related to epigenetic DNA...
Autores principales: | Song, Yongchun, Yang, Kui, Sun, Tuanhe, Tang, Ruixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841904/ https://www.ncbi.nlm.nih.gov/pubmed/33509178 http://dx.doi.org/10.1186/s12920-021-00876-4 |
Ejemplares similares
-
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways
por: Song, Yongchun, et al.
Publicado: (2019) -
Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma
por: Ding,, Dongxiao, et al.
Publicado: (2023) -
Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021) -
Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker
por: Wang, Yang, et al.
Publicado: (2023) -
Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022)